The sales of Enervit, the manufacturer of energy tablets listed on the Italian stock exchange in July, dropped by 1.2 percent to €19.7 million in the first half from €19.9 million a year earlier due to a decline of more than €400,000 at Zest12, a unit which distributes its products in Switzerland. By distribution channels, revenues rose by 7.2 percent in pharmacies and by 5.5 percent in sports outlets, but fell by 24.4 percent abroad and by 4.8 percent in supermarkets. Enervit nevertheless managed to boost gross operating profits (EBITDA) thanks to cost containment. EBITDA rose by 8.5 percent to €2.1 million from €1.9 million. EBIT jumped by 21.7 percent to €1.7 million as provisions and depreciations were slashed to €43,000 from €185,000. Net profits increased by 19.7 percent to €942,000 from €787,000 a year earlier. Net debt swelled to €1.6 million at the end of June from €0.1 million at the end of December for seasonality reasons and the company expects its financial position to improve in the second half of the year.